Genetically enhanced, cord-blood derived immune cells strike B-cell cancers – Science Daily
|
Genetically enhanced, cord-blood derived immune cells strike B-cell cancers
Science Daily A proportion of mice treated with the higher dose of engineered NK cells died of cytokine release syndrome, a severe inflammatory response that also occurs in people treated with CAR T cells. To counteract this toxicity, the researchers incorporated a … |
